Amgen(US:AMGN) Prnewswire·2025-03-04 21:54Core Points - Amgen's Board of Directors declared a dividend of $2.38 per share for Q2 2025, payable on June 6, 2025, to stockholders of record as of May 16, 2025 [1] Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines for various diseases, leveraging over 40 years of industry experience [2] - The company has a broad pipeline aimed at treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [2] Recognition and Market Position - In 2024, Amgen was recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [3] - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its status as one of the largest and most innovative non-financial companies [3]